Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanick J Crow

Showing results (31-40 of 233) with videos related to

Pageof 24
Sort By:
The Lancet. Neurology|February 26, 2011
Paediatric stroke: genetic insights into disease mechanisms and treatment targetsPinki Munot, Yanick J Crow, Vijeya Ganesan
Annual Review of Immunology|January 12, 2019
Self-Awareness: Nucleic Acid-Driven Inflammation and the Type I InterferonopathiesCarolina Uggenti, Alice Lepelley, Yanick J Crow
The Journal of Allergy and Clinical Immunology|August 10, 2021
JAK inhibition in the type I interferonopathiesYanick J Crow, Bénédicte Neven, Marie-Louise Frémond
Nature Reviews. Immunology|June 15, 2026
Nuclear STING compromises replication fidelityMarie-Therese A El-Daher, Yanick J Crow
Developmental Medicine and Child Neurology|June 9, 2019
Treatments in Aicardi-Goutières syndromeYanick J Crow, Jayakara Shetty, John H Livingston
American Journal of Medical Genetics. Part A|June 9, 2009
3C syndromeEmily Craft, Catherine E Wildig, Yanick J Crow
Nature Immunology|June 21, 2017
Polymorphisms in IFIH1: the good and the badErika Della Mina, Mathieu P Rodero, Yanick J Crow
Journal of Clinical Immunology|October 2, 2024
MDA5 gain-of-function associated with a Glu794del mutationCallie Wong, Lukas Gerasimavicius, Yanick J Crow, et al.
Journal of Clinical Immunology|March 4, 2015
Human disease phenotypes associated with mutations in TREX1Gillian I Rice, Mathieu P Rodero, Yanick J Crow
Arthritis & Rheumatology (Hoboken, N.J.)|January 23, 2014
Reply: To PMID 23666743Alexandre Belot, John Brognard, Yanick J Crow, et al.
Pageof 24

Showing results (31-40 of 233) with videos related to

Sort By:
Pageof 24
The Lancet. Neurology|February 26, 2011
Paediatric stroke: genetic insights into disease mechanisms and treatment targetsPinki Munot, Yanick J Crow, Vijeya Ganesan
Annual Review of Immunology|January 12, 2019
Self-Awareness: Nucleic Acid-Driven Inflammation and the Type I InterferonopathiesCarolina Uggenti, Alice Lepelley, Yanick J Crow
The Journal of Allergy and Clinical Immunology|August 10, 2021
JAK inhibition in the type I interferonopathiesYanick J Crow, Bénédicte Neven, Marie-Louise Frémond
Nature Reviews. Immunology|June 15, 2026
Nuclear STING compromises replication fidelityMarie-Therese A El-Daher, Yanick J Crow
Developmental Medicine and Child Neurology|June 9, 2019
Treatments in Aicardi-Goutières syndromeYanick J Crow, Jayakara Shetty, John H Livingston
American Journal of Medical Genetics. Part A|June 9, 2009
3C syndromeEmily Craft, Catherine E Wildig, Yanick J Crow
Nature Immunology|June 21, 2017
Polymorphisms in IFIH1: the good and the badErika Della Mina, Mathieu P Rodero, Yanick J Crow
Journal of Clinical Immunology|October 2, 2024
MDA5 gain-of-function associated with a Glu794del mutationCallie Wong, Lukas Gerasimavicius, Yanick J Crow, et al.
Journal of Clinical Immunology|March 4, 2015
Human disease phenotypes associated with mutations in TREX1Gillian I Rice, Mathieu P Rodero, Yanick J Crow
Arthritis & Rheumatology (Hoboken, N.J.)|January 23, 2014
Reply: To PMID 23666743Alexandre Belot, John Brognard, Yanick J Crow, et al.
Pageof 24